אבוסינאגיס 100 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

PALIVIZUMAB 100 MG

Pieejams no:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

ATĶ kods:

J06BB16

Zāļu forma:

POWDER FOR SOLUTION FOR INJECTION

Ievadīšanas:

I.M

Ražojis:

ABBVIE S.R.L., ITALY

Ārstniecības grupa:

PALIVIZUMAB

Ārstēšanas norādes:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Autorizācija datums:

2010-06-01